DNA diagnostics in Congenital Stationary Nightblindness (CSNB).

DNA diagnostics in Congenital Stationary Nightblindness (CSNB). - DNA diagnostics in Congenital Stationary Nightblindness.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35547

Enrollment

300

Registered

2010-09-17

Start date

2010-05-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital stationary nightblindness nightblindness

Interventions

None listed

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who are diagnosed with CSNB based on ERG (electroretinogram) and DA (dark adaptation curve) measurements and never underwent a DNA test, plus none affected familiemembers

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
To study the correlation between the genotype and the fenotype (clinical symptoms) of CSNB patients.	—

Secondary

Measure	Time frame
To find yet undiscovered genes responsible for the disorder CSNB.	—

Countries

Netherlands

Outcome results